Home
Robert Spiegel Board Membership
About Robert Spiegel
- Dr. Robert Spiegel, holding DIN: 08739625, has been appointed as an Independent Director of Sun Pharma Advanced Research Company Ltd for a term of five years.
- His role as an Independent Director contributes to the governance and strategic oversight of the company's pharmaceutical research and development activities.
List of Companies Associated with Robert Spiegel
| Company Name | Position Held | Market Cap | Sector | Date Of Appointment |
|---|
| Sun Pharma Advanced Research Company Ltd | Independent Director | 7008.04 | Pharmaceuticals | Mar, 2022 |
| Company Name |  Position Held |
|---|---|
| Sun Pharma Advanced Research Company Ltd | Independent Director |
Historical Share Prices
Robert Spiegel Sector Specific Experience
About Robert Spiegel's Work Experience
- Robert Spiegel is currently a Independent Director in Sun Pharma Advanced Research Company Ltd (as of Mar 2024).
- Robert Spiegel is serving the company - Sun Pharma Advanced Research Company Ltd at this position since 2022 for the last 4+ years.
- Prior to becoming Independent Director, Robert Spiegel was Additional Director of Sun Pharma Advanced Research Company Ltd for 2 years from 2019 to 2020.
FAQ's related Robert Spiegel
Who is Robert Spiegel
Dr. Robert Spiegel, holding DIN: 08739625, has been appointed as an Independent Director of Sun Pharma Advanced Research Company Ltd for a term of five years. His role as an Independent Director contributes to the governance and strategic oversight of the company's pharmaceutical research and development activities.
Which companies does Robert Spiegel serve as a board member for?
Robert Spiegel serves as a board member for: Sun Pharma Advanced Research Company Ltd
What positions has Robert Spiegel held in his/her career?
Throughout their career, Robert Spiegel has held key positions such as Independent Director,Additional Director, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
